World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Teva Poised to Get a Big Boost in Generics
Keywords:
Tags:
Teva Pharmaceutical plans to acquire the generic drug business of Allergan in 2015. Teva's sales of generics were $9.1 billion in 2014, according to EvaluatePharma, over 50% of its total sales, and 12% of global market. Alergan had $6.6 billion in generic sales in 2014. Allergan's strategy is to move up the market to branded drugs because of price competition from India in generic drugs. Teva's strategy is to increase the size of its generic business to better tackle pricing issues.
Teva acquisitions.
07/26/2005
Grouped Articles
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Pharmaceuticals to Buy Allergan’s Generics Business
New York Times 07/27/2015
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07/26/2005
Teva to Buy U.S. Generic Rival Barr for $7.46 Billion
Wall Street Journal 07/19/2008
Teva Deal Probe Gets Extension
Wall Street Journal 12/03/2008
Teva Pharmaceutical
05/21/2007
Grouped Articles
Wall Street Journal 10/11/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Generic Approved; Court Blocks Launch
Wall Street Journal 05/21/2007
Wyeth Loses Bout in Fight on a Generic
New York Times 09/08/2007
Wyeth Hit by Generic Competition and Regulatory Setback
New York Times 12/25/2007
Teva Pharmaceutical financial performance- 2011-2015
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Wall Street Journal 05/12/2011
Teva Pharmaceutical's strategy
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Threat of Generic Copycat Comes Back to Nip at Teva
Wall Street Journal 07/25/2011
Allergan Inc. performance
01/23/2013
Grouped Articles
Allergan to Lay Off 13% of Workforce, Cut Drug Research
Wall Street Journal 07/22/2014
Actavis Agrees to Buy Botox Maker Allergan
Wall Street Journal 11/19/2014
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Pfizer, Allergan Agree on Historic Merger Deal
Wall Street Journal 11/23/2015
Allergan to Buy MAP for $958 Million
Wall Street Journal 01/23/2013
Eli Hurvitz, founder of Teva Pharmaceuticals
11/23/2011
Hurvitz went from kibbutz to founder of Israel's leading drug company. Teva means "nature" in Hebrew. One in five prescription medications in the U.S. in 2011 were made by Teva Pharmaceutical.
Grouped Articles
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Former Test-Tube Washer Built Generic-Drug Maker Teva
Wall Street Journal 11/23/2011
Teva Names a New Chief Executive
New York Times 01/02/2012
Wall Street Journal 05/08/2012
Teva Pharmaceutical and at-risk launches of generic drugs
06/15/2013
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/31/2013
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Pharmaceuticals Hit by Increased Competition in U.S. Generics
WSJ 08/03/2017
Teva Pharmaceutical management
05/12/2011
Grouped Articles
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Former Test-Tube Washer Built Generic-Drug Maker Teva
Wall Street Journal 11/23/2011
Teva Names a New Chief Executive
New York Times 01/02/2012
Wall Street Journal 05/08/2012
Teva Pharmaceutical quality and safety issues
05/28/2010
Grouped Articles
Teva Will Stop Making Anesthetic
Wall Street Journal 05/28/2010
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Allergan Inc. strategies
01/23/2013
Grouped Articles
Allergan to Lay Off 13% of Workforce, Cut Drug Research
Wall Street Journal 07/22/2014
Actavis Agrees to Buy Botox Maker Allergan
Wall Street Journal 11/19/2014
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Pfizer, Allergan Agree on Historic Merger Deal
Wall Street Journal 11/23/2015
Allergan to Buy MAP for $958 Million
Wall Street Journal 01/23/2013
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us